This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

CW Group-Sigma Healthcare deal could harm wholesale markets, Australian watchdog warns

( June 13, 2024, 00:09 GMT | Official Statement) -- MLex Summary: The proposed merger between pharmacy giant CW Group, the owner of the Chemist Warehouse franchise, and the publicly listed Sigma Healthcare could harm pharmacies currently supplied by Sigma and lead to a substantial lessening of competition, Australia’s antitrust regulator has warned. In a statement of issues signaling the start of an in-depth review, the Australian Competition & Consumer Commission said that while Sigma us currently incentivized to maximize wholesale sales, after the transaction the independent pharmacies it supplies will also be competitors to Chemist Warehouse. The ACCC has set Sept. 5 as the deadline for a final decision.  The ACCC's statement of issues is attached; the full statement from the ACCC follows: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents